Cathepsins are lysosomal cysteine proteases, and their aberrant expression is related to the malignancy of tumors, and thus, the inhibition of cathepsins by CSTA expression has been considered to be a target for cancer treatment [71]. This evidence concerns the gene CSTA and cancer.